Plain-English translation of NCT06628453 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two ways of monitoring blood sugar during pregnancy for women with type 2 diabetes. About half of participants will wear a Dexcom G7 continuous glucose monitor—a small device that reads your blood sugar automatically throughout the day—while the other half will use traditional finger-stick testing (pricking your finger multiple times daily). The study wants to see which method helps you and your baby stay healthier during pregnancy and delivery.
Keeping blood sugar well-controlled during pregnancy is crucial for both you and your baby's health, but many pregnant women struggle to achieve good control with standard finger-stick testing alone. This trial wants to know whether the convenience and real-time feedback of a continuous monitor helps pregnant women with type 2 diabetes manage their condition more effectively.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either wear the continuous glucose monitor or stick with traditional finger-stick testing throughout your pregnancy. You'll have study visits around 6–22 weeks (enrollment), 24 weeks, 34 weeks, and at delivery. At each visit, you'll have blood work done to check your average blood sugar levels and other health markers. If you're in the monitor group, you'll replace the small sensor every 10 days and learn to read and respond to the real-time data. If you're in the finger-stick group, you'll test your blood sugar at least 4 times daily and check in with your provider every 1–2 weeks; you'll also wear a hidden monitor for 10 days at three timepoints so researchers can compare results fairly between groups.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States